Balancing benefits and risks for cystic fibrosis newborn screening: implications for policy decisions-Reference-Cited by-同舟云学术

Balancing benefits and risks for cystic fibrosis newborn screening: implications for policy decisions

Published:2005-09 Issue:3 Volume:147 Page:S109-S113
ISSN:0022-3476
Container-title:The Journal of Pediatrics
language:en
Short-container-title:The Journal of Pediatrics

Author:

Wilfond Benjamin S.,Parad Richard B.,Fost Norman

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology, and Child Health

Reference42 articles.

1. Models of public health genetic policy development;Wilfond,2000

2. Newborn screening for cystic fibrosis: ensuring more good than harm;Farrell;J Pediatr,2003

3. Screening policy for cystic fibrosis: the role of evidence;Wilfond;Hastings Cent Rep,1995

4. Principles and practice of screening for disease;Wilson,1968

5. Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs;Centers of Disease Control and Prevention;MMWR,2004

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protocolo de seguimiento de pacientes con fibrosis quística diagnosticados por cribado neonatal;Anales de Pediatría;2019-04

2. Follow-up protocol of patients with cystic fibrosis diagnosed by newborn screening;Anales de Pediatría (English Edition);2019-04

3. Bioética y políticas públicas de tamización neonatal en los Estados Unidos, el Reino Unido y Colombia;Biomédica;2019-03-31

4. Including ELSI research questions in newborn screening pilot studies;Genetics in Medicine;2019-03

5. False-Positive Newborn Screening for Cystic Fibrosis and Health Care Use;Pediatrics;2017-11-01